Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia
Abstract The mitochondrial enzyme dihydroorotate dehydrogenase (DHODH) catalyzes one of the rate‐limiting steps in de novo pyrimidine biosynthesis, a pathway that provides essential metabolic precursors for nucleic acids, glycoproteins, and phospholipids. DHODH inhibitors (DHODHi) are clinically use...
Main Authors: | Joan So, Alexander C Lewis, Lorey K Smith, Kym Stanley, Rheana Franich, David Yoannidis, Lizzy Pijpers, Pilar Dominguez, Simon J Hogg, Stephin J Vervoort, Fiona C Brown, Ricky W Johnstone, Gabrielle McDonald, Danielle B Ulanet, Josh Murtie, Emily Gruber, Lev M Kats |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2022-05-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.202115203 |
Similar Items
-
Retinoblastoma vulnerability to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage
by: Tanzina Mollick, et al.
Published: (2024-01-01) -
The Anti-Leukemic Activity of Natural Compounds
by: Coralia Cotoraci, et al.
Published: (2021-05-01) -
Acute appendicitis with leukemic infiltration in a child with acute myeloid leukemia: A case report
by: Ana Laura Moraes Luzardi, et al.
Published: (2023-12-01) -
Difficulties in the differential diagnosis of myelodysplastic syndrome and acute leukemia
by: Alina V. Maltseva, et al.
Published: (2023-05-01) -
Understanding the Hedgehog Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Necessary Step toward a Cure
by: Daniel Lainez-González, et al.
Published: (2021-03-01)